Neuralink to scale brain implants, automate surgery, says Elon Musk

Elon Musk announced that Neuralink will scale up to high-volume production of its brain-computer interface devices in 2026, alongside transitioning to an almost fully automated surgical procedure. The implant, designed to aid individuals with conditions like spinal cord injuries, allows users to interact directly with computers. Neuralink began human trials in 2024 after overcoming FDA safety concerns, and as of September, 12 people with severe paralysis have received implants enabling control of digital and physical tools through thought. A notable advancement includes device threads that penetrate the dura mater without removal, simplifying surgery. Additionally, Neuralink plans to initiate trials of its Blindsight implant in 2026, targeting vision restoration for the completely blind by stimulating the visual cortex. Neuralink’s expansion is part of a broader set of ambitious projects Musk’s companies are pursuing in 2026. SpaceX aims to launch its Starship V3 spacecraft with new propulsion capabilities and conduct orbital refueling tests, alongside deploying upgraded Starlink V3 satellites for